Photo: Courtesy of Illumina, Inc (http://www.illumina.com/company/news-center/multimedia-images.html)
Genetics analysis company Illumina has sued Switzerland-based Genoma.
Illumina filed a patent infringement claim yesterday, April 21, at the Federal Patent Court of Switzerland.
The claim centres on four patents: European patent numbers 2,183,693 B1; 0,994,963 B2; 1,981,995 B1; and 2,514,842, which cover cell-free fetal DNA used for non-invasive pre-natal testing (NIPT).
Illumina has accused Genoma’s Tranquility NIPT testing service of infringing its patents.
Charles Dadswell, senior vice president at Illumina, said: “We will continue to monitor activities in the NIPT field and file suits where appropriate to protect our substantial investments in this technology covered by our intellectual property.”
Illumina, Genoma, patent, patent infringement, DNA, NIPT
